# BASel Kosten-Effektivitäts-Trial: Drug-coated BALLoon (DCB) vs. Drug-eluting Stent (DES) Strategy in High-risk Patients With Coronary Artery Disease (CAD)

Study · id `cardio:ct-nct07363161` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07363161](<https://clinicaltrials.gov/study/NCT07363161>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07363161

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2184 participants.

## Technical summary

Registry record NCT07363161. Randomized; no masking; primary purpose treatment. Start 2026-06-17 (actual); primary completion 2027-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 2184 participants (planned count; ClinicalTrials.gov record NCT07363161, source copy `cardio:ctgov-nct07363161-2026-07-20`, retrieved 2026-10-26)
- Started: 2026-06-17 (actual) (ClinicalTrials.gov record NCT07363161, source copy `cardio:ctgov-nct07363161-2026-07-20`, retrieved 2026-10-26)
- Primary completion: 2027-06 (anticipated) (ClinicalTrials.gov record NCT07363161, source copy `cardio:ctgov-nct07363161-2026-07-20`, retrieved 2026-10-26)
- Completion: 2031-03 (anticipated) (ClinicalTrials.gov record NCT07363161, source copy `cardio:ctgov-nct07363161-2026-07-20`, retrieved 2026-10-26)
- Countries: Germany; Switzerland (ClinicalTrials.gov record NCT07363161, source copy `cardio:ctgov-nct07363161-2026-07-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07363161-2026-07-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: BASel Kosten-Effektivitäts-Trial: Drug-coated BALLoon (DCB) vs. Drug-eluting Stent (DES) Strategy in High-risk Patients With Coronary Artery Disease (CAD)
- Acronym: BASKET BALL
- Condition: Coronary Artery Disease (CAD)
- Intervention (Device): PCI
- Intervention (Device): PCI
- Lead sponsor: B. Braun Melsungen AG
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: B. Braun Melsungen AG (`cardio:org-b-braun-melsungen-ag`)

## Provenance

Content hash: 7d576c696fec10d13e73d2c71c6c3dabcbef9ab0c654bc1fa8086925974ad7d2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
